Gupta S, Bachanova V. CD19-directed chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma: lessons learned from clinical trials and real world evidence. Leuk Lymphoma 2025 Oct 10:1-13. doi: 10.1080/10428194.2025.2560082.
PMID: 41070560